Cryo-Cell International Inc. (CCEL)
Score for how it compares with the broader market is near the top of its range — price trend score is near the top of its range.
CCEL scores higher than 99% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, Cryo-Cell International Inc. (CCEL) scores 73 out of 100 on the Market Census six-factor composite, which puts it at the High score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.41× 30-day average
- 52-week range
- 2.72 – 4.90
- Market cap
- $35.48M
- Earnings date
- —
- Volume
- 5,470
- Avg. volume (30d)
- 13,496
- Open
- 4.00
- Previous close
- 4.17
- Day's range (regular session)
- 4.00 – 4.47
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.61
- P/E (TTM)
- —
- EPS (TTM)
- -0.31
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for CCEL
- 2 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for CCEL. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about CCEL right now
Cryo-Cell International Inc. (CCEL) currently scores 73/100 on the Market Census six-factor composite, at the High score level. CCEL is +4.56% on the day and +9.27% over five sessions as of the most recent tick. High is the level just below the top. The data for CCEL mostly reads well right now. It does not say what happens next. CCEL's strongest factor is strength vs the market at 99/100 — a very strong read on how CCEL has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is market mood at 50/100 — middling backdrop. A weak market mood drags every name in the cohort; if CCEL is still scoring well on the composite despite this, the company-specific factors must be doing heavy lifting.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See CCEL in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent CCEL news
Latest headlines that name Cryo-Cell International, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Cryo-Cell Intl (NYSEARCA:CCEL) Q3 Profit Surges Past Estimates on Flat RevenueChartMill
- Cryo-Cell International (NYSEARCA:CCEL) Shares Dip on Mixed Quarter Despite Earnings BeatChartMill
- Cryo-Cell International Q2 EPS $0.07 Up From $0.04 YoY, Sales $7.800M Down From $7.900M YoYBenzinga
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to CCEL’s 73, all within 2 points.
Sorted by closeness to CCEL’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.